NCT03226704View on ClinicalTrials.gov

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

Enrolling by invitationOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 14, 2017

Primary Completion Date

January 31, 2030

Study Completion Date

July 31, 2030

Conditions
LeukemiaLymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell LymphomaNon-Hodgkin's Lymphoma
Interventions
PROCEDURE

Leukapheresis

Leukapheresis

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH